Key statistics
Short selling activityProvided by S&P Global Market Intelligence
| Open | -- |
|---|---|
| High | -- |
| Low | -- |
| Bid | -- |
| Offer | -- |
| Previous close | -- |
| Average volume | -- |
|---|---|
| Shares outstanding | 14.42m |
| Free float | 13.72m |
| P/E (TTM) | 11.06 |
| Market cap | 150.27m USD |
| EPS (TTM) | 0.9419 USD |
Data delayed at least 15 minutes.
More ▼
- Anika to Issue Fourth Quarter and Year-End 2025 Financial Results on Thursday, February 26, 2026
- Anika Therapeutics Announces Leadership Transition
- Anika Therapeutics Reports Filing of Final PMA Module for Hyalofast® Cartilage Repair Scaffold and Data from U.S. Pivotal FastTRACK Phase III Study
- Anika to Issue Third Quarter 2025 Financial Results on Wednesday, November 5, 2025
- Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Anika Reports Topline Results from U.S. Pivotal FastTRACK Phase III Study for Hyalofast® Cartilage Repair Scaffold and Provides Program Update
- Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025
- Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
More ▼
